145 related articles for article (PubMed ID: 31951091)
1. Fluoroquinolone resistance in Haemophilus influenzae from nursing home residents in Taiwan: correlation of MICs and mutations in QRDRs.
Chang CM; Shih HI; Wu CJ; Lauderdale TL; Lee NY; Lee CC; Chen YC; Huang CC; Ko WC
J Appl Microbiol; 2020 Jun; 128(6):1624-1633. PubMed ID: 31951091
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.
Puig C; Tirado-Vélez JM; Calatayud L; Tubau F; Garmendia J; Ardanuy C; Marti S; de la Campa AG; Liñares J
Antimicrob Agents Chemother; 2015 Jan; 59(1):461-6. PubMed ID: 25385097
[TBL] [Abstract][Full Text] [Related]
3. Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.
Pérez-Vázquez M; Román F; Aracil B; Cantón R; Campos J
J Clin Microbiol; 2004 Mar; 42(3):1185-91. PubMed ID: 15004073
[TBL] [Abstract][Full Text] [Related]
4. GyrA and/or ParC alterations of Haemophilus influenzae strains isolated from the urethra of men with acute urethritis.
Kondo H; Ito S; Hatazaki K; Horie K; Nakane K; Mizutani K; Tsuchiya T; Yasuda M; Yokoi S; Nakano M; Deguchi T
J Infect Chemother; 2018 Mar; 24(3):232-235. PubMed ID: 29138021
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of garenoxacin (BMS-284756) against Haemophilus influenzae isolates with different fluoroquinolone susceptibilities.
Pérez-Vázquez M; Román F; Aracil B; Cantón R; Campos J
Antimicrob Agents Chemother; 2003 Nov; 47(11):3539-41. PubMed ID: 14576114
[TBL] [Abstract][Full Text] [Related]
6. Microbial virulence, molecular epidemiology and pathogenic factors of fluoroquinolone-resistant Haemophilus influenzae infections in Guangzhou, China.
Chen D; Wen S; Feng D; Xu R; Liu J; Peters BM; Su D; Lin Y; Yang L; Xu Z; Shirtliff ME
Ann Clin Microbiol Antimicrob; 2018 Nov; 17(1):41. PubMed ID: 30470228
[TBL] [Abstract][Full Text] [Related]
7. Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.
Yokoi S; Yasuda M; Ito S; Takahashi Y; Ishihara S; Deguchi T; Maeda S; Kubota Y; Tamaki M; Fukushi H
J Infect Chemother; 2004 Oct; 10(5):262-7. PubMed ID: 16163459
[TBL] [Abstract][Full Text] [Related]
8. A molecular analysis of quinolone-resistant Haemophilus influenzae: validation of the mutations in Quinolone Resistance-Determining Regions.
Shoji H; Shirakura T; Fukuchi K; Takuma T; Hanaki H; Tanaka K; Niki Y
J Infect Chemother; 2014 Apr; 20(4):250-5. PubMed ID: 24480551
[TBL] [Abstract][Full Text] [Related]
9. Earlier generation quinolones can be useful in identifying Haemophilus influenzae strains with low susceptibility to quinolone isolated from paediatric patients.
Tanaka E; Wajima T; Noguchi N
J Med Microbiol; 2019 Aug; 68(8):1227-1232. PubMed ID: 31215858
[TBL] [Abstract][Full Text] [Related]
10.
Honda H; Sato T; Shinagawa M; Fukushima Y; Nakajima C; Suzuki Y; Kuronuma K; Takahashi S; Takahashi H; Yokota SI
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31740553
[No Abstract] [Full Text] [Related]
11. In vitro antibacterial activities of new fluoroquinolones against clinical isolates of haemophilus influenzae with ciprofloxacin-resistance-associated alterations in GyrA and ParC.
Yoshizumi S; Takahashi Y; Watanabe Y; Okezaki E; Ishii Y; Tateda K
Chemotherapy; 2004 Dec; 50(6):265-75. PubMed ID: 15608441
[TBL] [Abstract][Full Text] [Related]
12. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
[TBL] [Abstract][Full Text] [Related]
13. Quinolone-resistant Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV.
Li X; Mariano N; Rahal JJ; Urban CM; Drlica K
Antimicrob Agents Chemother; 2004 Sep; 48(9):3570-2. PubMed ID: 15328129
[TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone-resistant Haemophilus influenzae: frequency of occurrence and analysis of confirmed strains in the SENTRY antimicrobial surveillance program (North and Latin America).
Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2000 Apr; 36(4):255-9. PubMed ID: 10764968
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.
Shigemura K; Shirakawa T; Okada H; Hinata N; Acharya B; Kinoshita S; Kofuku T; Kawabata M; Kamidono S; Arakawa S; Gotoh A
Sex Transm Dis; 2004 Mar; 31(3):180-4. PubMed ID: 15076932
[TBL] [Abstract][Full Text] [Related]
17. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the quinolone resistant determining regions in clinical isolates of pneumococci collected in Canada.
Patel SN; Melano R; McGeer A; Green K; Low DE
Ann Clin Microbiol Antimicrob; 2010 Jan; 9():3. PubMed ID: 20082699
[TBL] [Abstract][Full Text] [Related]
19. The roles of mutations in gyrA, parC, and ompK35 in fluoroquinolone resistance in Klebsiella pneumoniae.
Chen FJ; Lauderdale TL; Ho M; Lo HJ
Microb Drug Resist; 2003; 9(3):265-71. PubMed ID: 12959405
[TBL] [Abstract][Full Text] [Related]
20. Novel Ser79Leu and Ser81Ile substitutions in the quinolone resistance-determining regions of ParC topoisomerase IV and GyrA DNA gyrase subunits from recent fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
Korzheva N; Davies TA; Goldschmidt R
Antimicrob Agents Chemother; 2005 Jun; 49(6):2479-86. PubMed ID: 15917550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
